108 related articles for article (PubMed ID: 23411345)
21. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
22. Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.
Mantha AJ; Hanson JE; Goss G; Lagarde AE; Lorimer IA; Dimitroulakos J
Clin Cancer Res; 2005 Mar; 11(6):2398-407. PubMed ID: 15788691
[TBL] [Abstract][Full Text] [Related]
23. E-cadherin, as a negative regulator of invasive behavior of human trophoblast cells, is down-regulated by cyclosporin A via epidermal growth factor/extracellular signal-regulated protein kinase signaling pathway.
Zhao HB; Wang C; Li RX; Tang CL; Li MQ; Du MR; Hou XF; Li DJ
Biol Reprod; 2010 Sep; 83(3):370-6. PubMed ID: 20427760
[TBL] [Abstract][Full Text] [Related]
24. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
[TBL] [Abstract][Full Text] [Related]
25. T-cadherin loss promotes experimental metastasis of squamous cell carcinoma.
Philippova M; Pfaff D; Kyriakakis E; Buechner SA; Iezzi G; Spagnoli GC; Schoenenberger AW; Erne P; Resink TJ
Eur J Cancer; 2013 May; 49(8):2048-58. PubMed ID: 23369463
[TBL] [Abstract][Full Text] [Related]
26. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
27. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells.
Liu ZM; Huang HS
Cell Signal; 2006 Feb; 18(2):244-55. PubMed ID: 15961274
[TBL] [Abstract][Full Text] [Related]
28. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.
Ko JC; Ciou SC; Cheng CM; Wang LH; Hong JH; Jheng MY; Ling ST; Lin YW
Carcinogenesis; 2008 Jul; 29(7):1448-58. PubMed ID: 18544565
[TBL] [Abstract][Full Text] [Related]
29. TPA-induced signal transduction: a link between PKC and EGFR signaling modulates the assembly of intercellular junctions in Caco-2 cells.
Barbosa LA; Goto-Silva L; Redondo PA; Oliveira S; Montesano G; De Souza W; Morgado-Díaz JA
Cell Tissue Res; 2003 Jun; 312(3):319-31. PubMed ID: 12733059
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
Dajani OF; Meisdalen K; Guren TK; Aasrum M; Tveteraas IH; Lilleby P; Thoresen GH; Sandnes D; Christoffersen T
J Cell Physiol; 2008 Feb; 214(2):371-80. PubMed ID: 17654493
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.
Xia W; Mullin RJ; Keith BR; Liu LH; Ma H; Rusnak DW; Owens G; Alligood KJ; Spector NL
Oncogene; 2002 Sep; 21(41):6255-63. PubMed ID: 12214266
[TBL] [Abstract][Full Text] [Related]
32. EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin.
Maslova K; Kyriakakis E; Pfaff D; Frachet A; Frismantiene A; Bubendorf L; Ruiz C; Vlajnic T; Erne P; Resink TJ; Philippova M
FASEB J; 2015 Feb; 29(2):494-507. PubMed ID: 25381040
[TBL] [Abstract][Full Text] [Related]
33. Measurement of downstream kinase activity modulation as indicator of epidermal growth factor receptor inhibitor efficacy.
Dickerson WM; Saab A; Leong K; Miller M; Latterich M; Beausang LA; Alderman EM
Anal Biochem; 2014 Mar; 448():65-7. PubMed ID: 24316115
[TBL] [Abstract][Full Text] [Related]
34. EGFR phosphorylation-dependent formation of cell-cell contacts by Ras/Erks cascade inhibition.
Kang ES; Oh MA; Lee SA; Kim TY; Kim SH; Gotoh N; Kim YN; Lee JW
Biochim Biophys Acta; 2007 Jun; 1773(6):833-43. PubMed ID: 17368581
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of E-cadherin dependent cell-cell contact promotes MUC5AC mucin production through the activation of epidermal growth factor receptors.
Iwashita J; Ose K; Ito H; Murata J; Abe T
Biosci Biotechnol Biochem; 2011; 75(4):688-93. PubMed ID: 21512244
[TBL] [Abstract][Full Text] [Related]
36. Mechanical disruption of E-cadherin complexes with epidermal growth factor receptor actuates growth factor-dependent signaling.
Sullivan B; Light T; Vu V; Kapustka A; Hristova K; Leckband D
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35074920
[TBL] [Abstract][Full Text] [Related]
37. Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
Huang DH; Su L; Peng XH; Zhang H; Khuri FR; Shin DM; Chen ZG
Nanotechnology; 2009 Jun; 20(22):225102. PubMed ID: 19433879
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study.
Jabbarzadeh Kaboli P; Leong MP; Ismail P; Ling KH
Pharmacol Rep; 2019 Feb; 71(1):13-23. PubMed ID: 30343043
[TBL] [Abstract][Full Text] [Related]
39. p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation.
Damiano L; Di Stefano P; Camacho Leal MP; Barba M; Mainiero F; Cabodi S; Tordella L; Sapino A; Castellano I; Canel M; Frame M; Turco E; Defilippi P
Oncogene; 2010 Jun; 29(25):3677-90. PubMed ID: 20453886
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells.
Cheng JC; Klausen C; Leung PC
Mol Endocrinol; 2010 Aug; 24(8):1569-80. PubMed ID: 20610539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
